Hospital based clinical surveillance for dengue haemorrhagic fever in Bandung, Indonesia 1994-1995

被引:13
作者
Chairulfatah, A
Setiabudi, D
Agoes, R
van Sprundel, M
Colebunders, R
机构
[1] Padjadjaran State Univ, Sch Med, Dr Hasan Sadikin Gen Hosp, Dept Childhlth, Bandung, Indonesia
[2] Padjadjaran State Univ, Sch Med, Dr Hasan Sadikin Gen Hosp, Dept Parasitol, Bandung, Indonesia
[3] Univ Antwerp, Dept Epidemiol & Community Med, B-2610 Wilrijk, Belgium
[4] Inst Trop Med, B-2000 Antwerp, Belgium
关键词
dengue; dengue haemorrhagic fever; surveillance; Indonesia;
D O I
10.1016/S0001-706X(01)00180-2
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
In Indonesia, by law dengue haemorrhagic fever (DHF) cases must be reported within 24 h to the district health authority. The objective of this study was to evaluate the adequacy, accuracy and reporting delay of this reporting system. In four major hospitals of the city of Bandung, medical records of hospitalised DHF cases admitted between April 1994 and March 1995 were reviewed. This list of DHF cases was compared with the fist of reported cases to the Bandung Municipality Health Office. During the study period, 569 DHF cases and 81 dengue shock syndrome (DSS),cases were diagnosed. Only 199 (31%) of the 650 hospitalised cases with suspected DHF/DSS were reported to the Bandung Municipality Health Office. The percentage of fatal cases was significantly lower among all hospitalised cases 11/650 (1.7%) than among reported cases 5/199 (2.5%). In only 443 of the 583 hospitalised cases (76%) in which a dengue serological test was performed, was this test positive. Of the 199 reported DHF/DSS cases 151 (76%) had a positive haemagglutination inhibition test. This study shows that the surveillance system for DHF/DSS in Bandung should be strengthened. DHF/DSS cases should be reported on the basis of a diagnosis made during hospitalisation preferably after a serological confirmation is obtained. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 11 条
[1]  
[Anonymous], 1997, Dengue and dengue haemorrhagic fever, P1
[2]  
Centers forDisease Control Prevention., 1988, Morbidity and Mortality Weekly Report, V37, P1
[3]  
Chan Y. C., 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P702
[4]   TECHNIQUES FOR HEMAGGLUTINATION AND HEMAGGLUTINATION-INHIBITION WITH ARTHROPOD-BORNE VIRUSES [J].
CLARKE, DH ;
CASALS, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1958, 7 (05) :561-573
[5]  
EVANS AS, 1983, EPIDEMIOLOGY CONTROL, P43
[6]  
GOH KT, 1983, DENGUE HAEMORRHAGIC, P40
[7]  
Gubler D J, 1989, Bull Pan Am Health Organ, V23, P397
[8]   DENGUE AND DENGUE HEMORRHAGIC-FEVER [J].
HAYES, EB ;
GUBLER, DJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (04) :311-317
[9]  
LUDOVICE ZO, 1983, P 10 SEAMIC SEM DIS, P116
[10]  
*WHO, 1994, MOTH BAB PACK IMPL S, P1